Ketamine Dosing for Emergency Department Use
For procedural sedation in the ED, use ketamine 1-2 mg/kg IV (administered slowly over 60 seconds) or 4-5 mg/kg IM for dissociative sedation; for analgesia alone, use subdissociative doses of 0.1-0.3 mg/kg IV. 1
Dissociative Sedation (Procedural Sedation)
The most recent ACEP multidisciplinary consensus guidelines (2026) emphasize that ketamine produces dissociation at a threshold dose rather than following the traditional sedation continuum 2. This fundamental pharmacologic distinction means ketamine maintains airway reflexes and spontaneous ventilation while providing profound analgesia and amnesia.
Intravenous Dosing
- Initial dose range: 1-4.5 mg/kg IV 1
- Standard effective dose: 2 mg/kg IV produces 5-10 minutes of surgical anesthesia within 30 seconds 1
- Dissociative threshold: Approximately 1-1.5 mg/kg IV in adults and teenagers; 1.5-2 mg/kg IV in children 2
- Administration rate: Give slowly over 60 seconds to avoid respiratory depression and enhanced vasopressor response 1
- Alternative: May administer as infusion at 0.5 mg/kg/min 1
Intramuscular Dosing
- Dose range: 6.5-13 mg/kg IM 1
- Standard dose: 9-13 mg/kg IM produces surgical anesthesia within 3-4 minutes, lasting 12-25 minutes 1
- Clinical note: IM administration results in lower incidence of emergence reactions 1
Maintenance Dosing
- Repeat increments: One-half to full induction dose as needed 1
- Continuous infusion: 0.1-0.5 mg/minute (or 0.1-0.5 mg/kg/min) maintains general anesthesia 1
Subdissociative Analgesia
For pain management without full dissociation, lower doses are highly effective and increasingly used in the ED setting.
Analgesic Dosing
- Standard range: 0.1-0.3 mg/kg IV 3, 4
- Specific dose: 0.15-0.30 mg/kg IV provides analgesia comparable to morphine 3
- Clinical application: Effective for acute visceral pain, musculoskeletal pain, and as opioid adjunct 4
A large health system study of 210 patients receiving subdissociative ketamine found only 4% experienced neuropsychiatric adverse events, with excellent safety profile 5. Recent pediatric data (2024) showed 90% effectiveness with IV doses of 1-1.5 mg/kg 6.
Acute Agitation/Excited Delirium
Dose: 1-2 mg/kg IV or 4-5 mg/kg IM produces rapid tranquilization (<5 minutes) 4
This indication shows ketamine's versatility beyond procedural sedation, with favorable safety compared to traditional sedatives in agitated patients 5.
Age-Specific Considerations
Pediatric Patients
- IV dissociative dose: 1.5-2 mg/kg IV (higher threshold than adults) 2
- IM dose: 4-5 mg/kg IM 7
- Evidence: Level A recommendation from ACEP guidelines supports safe use in children 7
- Caveat: Children <2 years receiving IV ketamine had higher rates of unsatisfactory sedation (28.7%) 6
Adult Patients
- Standard IV dose: 2 mg/kg IV for procedural sedation 7
- Combined therapy: 0.07 mg/kg midazolam followed by 2 mg/kg ketamine showed excellent safety in 70 adults 7
Critical Administration Details
Preparation and Dilution
- 100 mg/mL concentration: Must be diluted 1:1 with sterile water, normal saline, or D5W before IV administration 1
- Maintenance infusion: Dilute to 1 mg/mL (10 mL of 50 mg/mL vial in 500 mL carrier) or 2 mg/mL if fluid restriction required 1
- Use immediately after dilution 1
Adjunctive Medications
Consider benzodiazepine coadministration to reduce emergence reactions (hallucinations, agitation, delirium) 1. The 2026 FDA label recommends benzodiazepines "if clinically indicated" for prevention of neuropsychological manifestations during emergence 1.
However, a high-quality RCT (Grade I evidence) in 266 pediatric patients found midazolam did not reduce emergence reactions 7. Adult data showed 13% recovery agitation rate, with half requiring midazolam treatment 8.
Antisialagogue
Administer antisialagogue prior to induction due to potential for increased salivation 1
Common Pitfalls and Safety Considerations
Dosing Errors to Avoid
- Rapid IV push: Causes respiratory depression and exaggerated cardiovascular response 1
- Underdosing: IV doses of 1.6-2 mg/kg had significantly higher failure rates (17.6%) compared to standard dosing 6
- Intranasal route: Shows 36.4% unsatisfactory effectiveness versus 15% with IV 6
Procedure-Specific Failures
Arthrocentesis had highest unsatisfactory sedation rate (39.3%) with IV ketamine 6. For procedures >20 minutes, plan for repeat dosing 6.
Cardiovascular Monitoring
Ketamine is contraindicated when blood pressure elevation would be hazardous 1. However, its sympathomimetic properties make it advantageous in trauma, burns, or shock where maintaining cardiovascular tone is critical 3.
Respiratory Considerations
Unlike other sedatives, ketamine preserves spontaneous ventilation and airway reflexes at dissociative doses 2. The 2026 ACEP guidelines explicitly state dissociative sedation is "fundamentally distinct" from general anesthesia because spontaneous ventilation is "almost always maintained" 2.
Emergence Phenomena
Occurs in approximately 12% of patients 1. Minimize verbal, tactile, and visual stimulation during recovery while maintaining vital sign monitoring 1. Duration is typically a few hours with no residual psychological effects 1.
Unique Pharmacology
Additional ketamine beyond the dissociative threshold does not deepen sedation—a critical distinction from all other procedural sedation agents 2. Purposeless or tonic-clonic movements may occur and do not indicate inadequate sedation or need for additional dosing 1.